These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
79 related items for PubMed ID: 15377549
21. Dynamics of retinal function after multiple photodynamic therapies in age-related macular degeneration: a report of cases. Feigl B, Brown B, Lovie-Kitchin J, Lee L. Doc Ophthalmol; 2005 Nov; 111(3):135-48. PubMed ID: 16523231 [Abstract] [Full Text] [Related]
22. Visual hallucinations and Charles Bonnet syndrome after photodynamic therapy for age related macular degeneration. Cohen SY, Bulik A, Tadayoni R, Quentel G. Br J Ophthalmol; 2003 Aug; 87(8):977-9. PubMed ID: 12881339 [Abstract] [Full Text] [Related]
28. Increasing use of a new health technology during the wait for NICE guidance: findings from the third national tracker survey of photodynamic therapy. Foot B, Foy R, Chakravarthy U, Wormald R. J Public Health (Oxf); 2004 Mar; 26(1):52-5. PubMed ID: 15044575 [Abstract] [Full Text] [Related]
29. Investigating the burden of wet macular degeneration. Mitchell J. Arch Ophthalmol; 2007 Sep; 125(9):1266-8. PubMed ID: 17846369 [No Abstract] [Full Text] [Related]
30. Self-reported visual functioning and quality of life in age-related macular degeneration. Chakravarthy U, Stevenson M. Curr Opin Ophthalmol; 2005 Jun; 16(3):179-83. PubMed ID: 15870576 [Abstract] [Full Text] [Related]
32. Validation and comparison of five preference-based measures among age-related macular degeneration patients: evidence from mainland China. Si Y, Li S, Xu Y, Chen G. Qual Life Res; 2022 May; 31(5):1561-1572. PubMed ID: 34853992 [Abstract] [Full Text] [Related]
33. Inhibition of photodynamic therapy induced-immunosuppression with aminolevulinic acid leads to enhanced outcomes of tumors and pre-cancerous lesions. Bayless S, Travers JB, Sahu RP, Rohan CA. Oncol Lett; 2021 Sep; 22(3):664. PubMed ID: 34386086 [Abstract] [Full Text] [Related]
34. Patient-Perceived Benefit of Treatment in Polypoidal Choroidal Vasculopathy: A Pilot Study. Ghoshal R, Sharanjeet-Kaur S, Fadzil NM, Ghosh S, Ngah NF, Aziz RAA. Int J Environ Res Public Health; 2020 Sep 02; 17(17):. PubMed ID: 32887213 [Abstract] [Full Text] [Related]
36. Human gaze following response is affected by visual acuity. Spoor M, Hosseini B, van Alphen B, Frens MA, van der Geest JN. J Ophthalmol; 2014 Sep 02; 2014():543478. PubMed ID: 24804079 [Abstract] [Full Text] [Related]
37. The quality of life impact of peripheral versus central vision loss with a focus on glaucoma versus age-related macular degeneration. Evans K, Law SK, Walt J, Buchholz P, Hansen J. Clin Ophthalmol; 2009 Sep 02; 3():433-45. PubMed ID: 19684867 [Abstract] [Full Text] [Related]
39. Quality of life in age-related macular degeneration: a review of available vision-specific psychometric tools. Finger RP, Fleckenstein M, Holz FG, Scholl HP. Qual Life Res; 2008 May 02; 17(4):559-74. PubMed ID: 18365767 [Abstract] [Full Text] [Related]